JUBLPHARMA.BOJUBLPHARMA.BOBSE
Loading
Earnings before interest, taxes, depreciation, and amortization
3Y CAGR
-0.6%/yr
vs -7.6%/yr prior
5Y CAGR
-7.5%/yr
Recent acceleration
Acceleration
+7.0pp
Accelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $10.48B | +32.1% |
| 2024 | $7.93B | +22.7% |
| 2023 | $6.46B | -39.4% |
| 2022 | $10.66B | -27.3% |
| 2021 | $14.68B | -5.2% |
| 2020 | $15.48B | -7.0% |
| 2019 | $16.64B | +13.7% |
| 2018 | $14.64B | +12.2% |
| 2017 | $13.05B | +11.3% |
| 2016 | $11.72B | - |